Feasibility of the intravascular lithotripsy in coronary artery disease. Short-term outcomes of the Lower-Silesia Shockwave Registry.
Piotr Rola, Adrian Włodarczak, Jan Jakub Kulczycki...
https://pubmed.ncbi.nlm.nih.gov/34415567/Actively Recruiting
Led by Regional Cardiology Center, The Copper Health Centre (MCZ), · Updated on 2023-06-23
400
Participants Needed
2
Research Sites
52 weeks
Total Duration
The Lower Silesia Shockwave Registry LSSR is an observational study collecting data on patients undergoing percutaneous coronary intervention PCI with the support of shockwave intravascular lithotripsy S-IVL in two cardiac centers in Poland. The study includes patients with highly calcified, resistant lesions or significantly under-expanded previously implanted stents, aiming to evaluate the safety and effectiveness of this device in improving stent deployment and vessel preparation. Patients in the registry received PCI supported by the S-IVL device, with operators deciding the initial lesion preparation and catheter size based on angiographic and optional intravascular imaging assessments. Drug-eluting stents or balloons were used at the operators discretion. The study does not restrict lesion anatomy and includes cases where advanced debulking procedures were initially performed. Clinical success and safety outcomes are measured, including effective stent deployment and serious angiographic complications. Participants are monitored during their hospital stay and followed up every six months for up to five years to track major adverse cardiac and cerebrovascular events MACCE such as death, myocardial infarction, stroke, or repeated revascularization. Data collection includes clinical evaluations by medical staff in person or by phone. The study has ethical approval and aims to provide long-term safety and efficacy data on using shockwave intravascular lithotripsy in coronary artery disease treatment.
CONDITIONS
The Lower Silesia Shockwave Registry
A
Adrian Włodarczak, M.D; Ph. D; Assoc Prof.
P
Piotr Rola, M.D.; Ph.D.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Regional Cardiology Center, The Copper Health Centre (MCZ),
Lead Sponsor
Provincial Specialized Hospital in Legnica
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Duration of the hospital stay for the procedure
Participants undergo coronary artery angioplasty or optimization of a previously implanted stent with the support of the Shockwave Intravascular Lithotripsy device.
1 visit (in-person) during the index hospitalization
Duration - Up to 5 years after the initial hospitalization with evaluations every 6 months
Participants are monitored for major adverse cardiac and cerebrovascular events (MACCE) through periodic evaluations.
Periodic visits or telephone contacts every 6 months
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Piotr Rola, Adrian Włodarczak, Jan Jakub Kulczycki...
https://pubmed.ncbi.nlm.nih.gov/34415567/Regional Cardiology Center, The Copper Health Centre (MCZ),
Lead Sponsor
Provincial Specialized Hospital in Legnica
Collaborating Sponsor